药物基因组学指导诊疗对用药依从性及依从相关心理因素的影响:叙述性综述
本文综述已发表文献,纳入23项研究,其中10项定量研究测量药物基因组学指导诊疗相关的用药依从性结局,5项发现药物基因组学检测组依从性有统计学显著改善,2项报告小但非显著趋势,3项无差异;另13项研究考察其对依从相关心理因素的影响,这些因素映射至10个TDF域。综述提示药物基因组学指导诊疗改善用药依从性的证据混杂且有限,但似可正向影响可能支持依从性的心理因素。
要点
- 10项定量研究中仅5项显示药物基因组学检测组用药依从性有统计学显著改善。
- 药物基因组学指导诊疗似可改善知识、支持决策并被患者视为正向体验。
- 依从相关心理因素可映射至理论域框架(TDF)10个域,信念后果与情绪域研究最多。
核心结论
- 药物基因组学指导诊疗改善用药依从性的证据混杂且有限。
- 药物基因组学指导诊疗似可正向影响可能支持依从性的心理因素。
研究设计与样本
- 叙述性综述,共纳入23项研究,其中10项定量研究测量药物基因组学指导诊疗相关的用药依从性结局。
- 另13项研究考察药物基因组学指导诊疗对依从相关心理因素的影响,并将这些因素映射至理论域框架(TDF)。
主要发现
- 10项定量研究中,5项发现药物基因组学检测组用药依从性有统计学显著改善。
- 2项报告小但非显著的依从性改善趋势,3项显示无差异。
- 13项心理因素研究映射至10个TDF域:知识(8项)、社会/专业角色与身份(1项)、能力信念(2项)、乐观(4项)、后果信念(10项)、意图(5项)、目标(1项)、记忆注意与决策过程(7项)、社会影响(4项)、情绪(8项)。
- 药物基因组学指导诊疗似可改善知识、支持决策,并普遍被患者视为正向体验。
临床怎么用
- 临床药学智能体医生应知晓药物基因组学指导诊疗改善用药依从性的证据尚不一致,不宜仅据此预期依从性必然提升。
- 可关注药物基因组学指导诊疗对患者知识、决策和情绪等心理因素的潜在正向影响,作为支持依从性的辅助环节。
局限性
- 证据混杂且有限,10项定量研究中仅5项显示依从性有统计学显著改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic-guided prescribing over a traditional one-size-fits-all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic-informed care, or that measure the impact of pharmacogenetic-informed care on psychological factors that are associated with medication adherence. Adherence-related psychological factors are mapped to the Theoretical Domains Framework (TDF) to provide insight into how participants interact with pharmacogenetic-informed care as an intervention and to consider this in the context of medication adherence. A total of 23 studies were included, with 10 quantitative studies measuring medication adherence outcomes associated with pharmacogenetic-informed care. Five of these studies found a statistically significant improvement in adherence in the pharmacogenetic-tested group, two reported a small but non-significant trend, and three showed no difference. Additionally, 13 studies examined the impact of pharmacogenetic-informed care on psychological factors related to adherence. These factors were mapped to 10 TDF domains: knowledge (8 studies); social/professional role and identity (1); beliefs about capabilities (2); optimism (4); beliefs about consequences (10); intentions (5); goals (1); memory, attention and decision processes (7); social influences (4); and emotion (8). The findings suggest that although the evidence for pharmacogenetic-informed care improving medication adherence is mixed and limited, pharmacogenetic-informed care appears to positively influence psychological factors that may support adherence. These include improving knowledge, supporting decision-making and generally being perceived as a positive experience by patients.
引用
- Galloway L, Wright A, Weinman J, et al. The impact of pharmacogenetic-informed care on medication adherence and psychological factors associated with adherence: A narrative review. Br J Clin Pharmacol. 2026. PMID: 42749995. doi:10.1002/bcp.70800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。